Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma

Twenty-five patients with advanced non-small-cell lung carcinoma (NSCLC) were treated with a multidrug regimen (CIV) consisting of ifosfamide (IFX), cisplatin (CDDP), and etoposide (VP-16). Twenty-four patients were evaluable for response. An objective response was detected in eight cases (33%), inc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical oncology 1990-10, Vol.13 (5), p.424-426
Hauptverfasser:	BIDOLI, P, SPINAZZE, S, SANTORO, A, CASALI, P, BEDINI, A. V, GUZZON, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Cisplatin - administration & dosage Drug Evaluation Etoposide - administration & dosage Female Humans Ifosfamide - administration & dosage Lung Neoplasms - drug therapy Male Medical sciences Middle Aged Pharmacology. Drug treatments Pilot Projects Remission Induction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!